Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02873377Phase 4Completed
Phase 4, randomised, open-label trial (2 arms), sponsored by University of Miami. Primary endpoint: Prolonged Abstinence Rates at 6 months. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02873377.